Recombinant CD19 (Loncastuximab Biosimilar) 抗体
Our Local Distributor
北京 101111
Quick Overview for Recombinant CD19 (Loncastuximab Biosimilar) 抗体 (ABIN7597795)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
质量等级
-
-
Expression System
- Mammalian cells
-
原理
- Research Grade Loncastuximab Biosimilar Antibody
-
特异性
- CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4
-
纯化方法
- Protein A or G purified from cell culture supernatant.
-
纯度
- >95 % by SDS-PAGE.
-
亚型
- IgG1 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 4.55 mg/mL
-
缓冲液
- 9 mM Citric acid monohydrat, 41 mM Na2HPO4, 1 % mannitol, 5 % trehalose, 0.02 % Tween20, pH 6.5
-
储存条件
- 4 °C,-20 °C,-80 °C
-
储存方法
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
有效期
- 12 months
-
-
- CD19 (Loncastuximab Biosimilar)
-
别名
- Loncastuximab Biosimilar
-
物质类
- Biosimilar
-
背景
- CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4
-
UniProt
- P15391
-
CAS-编号
- 1875032-68-0
抗原
-